Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_assertion type Assertion NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_head.
- NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_assertion description "[Immunohistochemical analyses of E2F3 protein levels have established that around one-third (33/101) of primary transitional cell carcinomas of the bladder overexpress nuclear E2F3 protein, with the proportion of tumours containing overexpressed nuclear E2F3 increasing with tumour stage and grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_provenance.
- NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_assertion evidence source_evidence_literature NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_provenance.
- NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_assertion SIO_000772 14716298 NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_provenance.
- NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_assertion wasDerivedFrom befree-20150227 NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_provenance.
- NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_assertion wasGeneratedBy ECO_0000203 NP363530.RAxNCbSYt2mkTUcIBRp2sbiInkjgwVup6ud5Tc05QseHo130_provenance.